Abstract
Background
Chronic liver diseases (CLD) present important clinical problem in children with various age-dependent causes. Nonalcoholic fatty liver disease (NAFLD) with its increasing prevalence is a major problem with regard to its timely recognition and the need for long-term disease monitoring. At present, a perfect non-invasive method for the evaluation of liver fibrosis is not available.
Methods
A non-systematic literature search was performed to summarize the current knowledge about transient elastography (TE) with controlled attenuation parameter (CAP) in children with CLD. Ovid MEDLINE, Ovid EMBASE, Google scholar, and The Cochrane Library databases were searched for relevant articles evaluating TE in the pediatric population.
Results
Normal values of liver stiffness measurements (LSM) according to the age are given, as well as the advantages and disadvantages of the method. The utility of TE in specific liver disease in pediatric population is summarized.
Conclusions
TE with CAP is a valuable non-invasive method for the liver-damage assessment. Clinical interpretation of TE results should be made in parallel with the assessment of the patient’s demographics, disease etiology, and essential laboratory parameters.
Similar content being viewed by others
References
Santos JL, Choquette M, Bezerra JA. Cholestatic liver disease in children. Curr Gastroenterol Rep. 2010;12:30–9.
Anderson EL, Howe LD, Jones HE, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS ONE. 2015;10:e0140908.
Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012;54:700–13.
Pinto RB, Schneider ACR, da Silveira TR. Cirrhosis in children and adolescents: an overview. World J Hepatol. 2015;7:392–405.
Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–57.
Castera L, Foucher J, Bernard P-H, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–35.
Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835–47.
Sandrin L, Fourquet B, Hasquenoph J-M, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.
Desai NK, Harney S, Raza R, Al-Ibraheemi A, Shillingford N, Mitchell PD, et al. Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients. J Pediatr. 2016;173:160–4.
Cho Y, Tokuhara D, Morikawa H, Kuwae Y, Hayashi E, Hirose M, et al. Transient elastography-based liver profiles in a hospital-based pediatric population in Japan. PLoS ONE. 2015;10:e0137239.
Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter [CAP]: a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36:13–20.
Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography [FibroScan®] with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease—where do we stand? World J Gastroenterol. 2016;22:7236–51.
Friedrich-Rust M, Ong M-F, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134:960–74.
de Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol. 2008;32:58–67.
Nguyen D, Talwalkar JA. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53:2107–10.
Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968–73.
de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007;45:443–50.
Engelmann G, Gebhardt C, Wenning D, Wuhl E, Hoffmann GF, Selmi B, et al. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012;171:353–60.
Goldschmidt I, Streckenbach C, Dingemann C, Pfister ED, di Nanni A, Zapf A, et al. Application and limitations of transient liver elastography in children. J Pediatr Gastroenterol Nutr. 2013;57:109–13.
Meierhenrich R, Gauss A, Muhling B, Bracht H, Radermacher P, Georgieff M, et al. The effect of propofol and desflurane anaesthesia on human hepatic blood flow: a pilot study. Anaesthesia. 2010;65:1085–93.
Ferraioli G, Lissandrin R, Zicchetti M, Filice C. Assessment of liver stiffness with transient elastography by using S and M probes in healthy children. Eur J Pediatr. 2012;171:1415.
Lewindon PJ, Balouch F, Pereira TN, Puertolas-Lopez MV, Noble C, Wixey JA, et al. Transient liver elastography in unsedated control children: impact of age and intercurrent illness. J Paediatr Child Health. 2016;52:637–42.
Tokuhara D, Cho Y, Shintaku H. Transient elastography-based liver stiffness age-dependently increases in children. PLoS ONE. 2016;11:e0166683.
Fitzpatrick E, Quaglia A, Vimalesvaran S, Basso MS, Dhawan A. Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease. J Pediatr Gastroenterol Nutr. 2013;56:72–6.
Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children’s hospital experience. J Pediatr. 2013;163:1058–64.
Behairy BE-S, Sira MM, Zalata KR, Salama E-SE, Abd-Allah MA. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: does etiology matter? World J Gastroenterol. 2016;22:4238–49.
Breton E, Bridoux-Henno L, Guyader D, Danielou H, Jouan H, Beuchee A, et al. Value of transient elastography in noninvasive assessment in children’s hepatic fibrosis. Arch Pediatr. 2009;16:1005–10.
Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology. 2008;48:442–8.
Shin NY, Kim MJ, Lee MJ, Han SJ, Koh H, Namgung R, et al. Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia. J Ultrasound Med. 2014;33:853–64.
Chongsrisawat V, Vejapipat P, Siripon N, Poovorawan Y. Transient elastography for predicting esophageal/gastric varices in children with biliary atresia. BMC Gastroenterol. 2011;11:41.
Chang HK, Park YJ, Koh H, Kim SM, Chung KS, Oh JT, et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr. 2009;49:323–8.
Colecchia A, Di Biase AR, Scaioli E, Predieri B, Iughetti L, Reggiani MLB, et al. Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. Dig Liver Dis. 2011;43:659–63.
Hahn SM, Kim S, Park KI, Han SJ, Koh H. Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia. PLoS ONE. 2013;8:e80652.
Malbrunot-Wagner AC, Bridoux L, Nousbaum JB, Riou C, Dirou A, Ginies JL, et al. Transient elastography and portal hypertension in pediatric patients with cystic fibrosis. Transient elastography and cystic fibrosis. J Cyst Fibros. 2011;10:338–42.
Van Biervliet S, Verdievel H, Vande Velde S, De Bruyne R, De Looze D, Verhelst X, et al. Longitudinal transient elastography measurements used in follow-up for patients with cystic fibrosis. Ultrasound Med Biol. 2016;42:848–54.
Witters P, De Boeck K, Dupont L, Proesmans M, Vermeulen F, Servaes R, et al. Non-invasive liver elastography [Fibroscan] for detection of cystic fibrosis-associated liver disease. J Cyst Fibros. 2009;8:392–9.
Aqul A, Jonas MM, Harney S, Raza R, Sawicki GS, Mitchell PD, et al. Correlation of transient elastography with severity of cystic fibrosis related liver disease. J Pediatr Gastroenterol Nutr. 2017;64:505–11.
Karlas T, Hempel M, Troltzsch M, Huster D, Gunther P, Tenckhoff H, et al. Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores. Scand J Gastroenterol. 2012;47:1353–61.
Goldschmidt I, Brauch C, Poynard T, Baumann U. Spleen stiffness measurement by transient elastography to diagnose portal hypertension in children. J Pediatr Gastroenterol Nutr. 2014;59:197–203.
Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, et al. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with Fibrosis. Clin Gastroenterol Hepatol. 2011;9:e1.
Kummer S, Klee D, Kircheis G, Friedt M, Schaper J, Haussinger D, et al. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis. Eur J Pediatr. 2017;176:529.
Shteyer E, Ramm GA, Xu C, White FV, Shepherd RW. Outcome after portoenterostomy in biliary atresia: pivotal role of degree of liver fibrosis and intensity of stellate cell activation. J Pediatr Gastroenterol Nutr. 2006;42:93–9.
Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr. 2004;144:123–5.
Wu JF, Lee CS, Lin WH, Jeng YM, Chen HL, Ni YH, et al. Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy. Hepatology. 2018;68:616–24.
Diwakar V, Pearson L, Beath S. Liver disease in children with cystic fibrosis. Paediatr Respir Rev. 2001;2:340–9.
Menten R, Leonard A, Clapuyt P, Vincke P, Nicolae A-C, Lebecque P. Transient elastography in patients with cystic fibrosis. Pediatr Radiol. 2010;40:1231–5.
Klotter V, Gunchick C, Siemers E, Rath T, Hudel H, Naehrlich L, et al. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study. PLoS ONE. 2017;12:e0178784.
Gominon AL, Frison E, Hiriart JB, Vergniol J, Clouzeau H, Enaud R, et al. Assessment of liver disease progression in cystic fibrosis using transient elastography. J Pediatr Gastroenterol Nutr. 2018;66:455–60.
Stefanescu AC, Pop TL, Stefanescu H, Miu N. Transient elastography of the liver in children with Wilson’s disease: preliminary results. J Clin Ultrasound. 2016;44:65–7.
Goldschmidt I, Brauch C, Poynard T, Baumann U. Spleen stiffness measurement by transient elastography to diagnose portal hypertension in children. J Pediatr Gastroenterol Nutr. 2014;59:197–203.
Hukkinen M, Kivisaari R, Lohi J, Heikkila P, Mutanen A, Merras-Salmio L, et al. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure. Liver Int. 2016;36:361–9.
Vinciguerra T, Brunati A, David E, Longo F, Pinon M, Ricceri F, et al. Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children. Pediatr Transplant. 2018;22:e13125.
Funding
None.
Author information
Authors and Affiliations
Contributions
All authors have contributed to conception, drafting, and revision of the article. The final version has been read and approved by all authors.
Corresponding author
Ethics declarations
Ethical approval
Not required for this review article.
Conflict of interest
None.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ruzman, L., Mikolasevic, I., Baraba Dekanic, K. et al. Advances in diagnosis of chronic liver diseases in pediatric patients. World J Pediatr 14, 541–547 (2018). https://doi.org/10.1007/s12519-018-0197-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-018-0197-8